National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts.org
Search Results

From the 1/7/2022 release of VAERS data:

Found 265 cases where Age is under-19 and Vaccine is COVID19 and Manufacturer is PFIZER/BIONTECH and Patient Did Not Die and Hospitalized and Vaccination Date from '2021-07-01' to '2021-07-31'

Government Disclaimer on use of this data



Case Details

This is page 9 out of 27

Result pages: prev   1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18   next


VAERS ID: 1531683 (history)  
Form: Version 2.0  
Age: 17.0  
Sex: Male  
Location: New York  
Vaccinated:2021-07-31
Onset:2021-08-03
   Days after vaccination:3
Submitted: 0000-00-00
Entered: 2021-08-06
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 2 - / -

Administered by: Unknown       Purchased by: ?
Symptoms: Magnetic resonance imaging heart, Myocarditis, Troponin increased
SMQs:, Myocardial infarction (narrow), Cardiomyopathy (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Immune-mediated/autoimmune disorders (broad)

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 3 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: troponin positive 8/3/2021, cardiac MRI 8/4/2021
CDC Split Type:

Write-up: myopericarditis - admitted hospital August 3-5, 2021


VAERS ID: 1531815 (history)  
Form: Version 2.0  
Age: 12.0  
Sex: Female  
Location: Arkansas  
Vaccinated:2021-07-22
Onset:2021-07-29
   Days after vaccination:7
Submitted: 0000-00-00
Entered: 2021-08-06
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 1 - / IM

Administered by: Private       Purchased by: ?
Symptoms: Immunoglobulin therapy, Petechiae, Platelet count decreased, Purpura
SMQs:, Haematopoietic thrombocytopenia (narrow), Haemorrhage terms (excl laboratory terms) (narrow), Systemic lupus erythematosus (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: None
Current Illness: None
Preexisting Conditions: None
Allergies:
Diagnostic Lab Data:
CDC Split Type:

Write-up: Patient presented 1 week after COVID with petechiae and purpura. She had platelet count <2,000 that has been refractory to ITP front line treatments including IVIG x 2, corticosteroids and romiplostim.


VAERS ID: 1532007 (history)  
Form: Version 2.0  
Age: 16.0  
Sex: Male  
Location: Wisconsin  
Vaccinated:2021-07-06
Onset:2021-07-09
   Days after vaccination:3
Submitted: 0000-00-00
Entered: 2021-08-06
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EW0198 / 2 RA / IM

Administered by: Private       Purchased by: ?
Symptoms: Chest pain, Electrocardiogram ST segment elevation, Headache, Laboratory test, Myocarditis, Nausea, Painful respiration, Pericarditis, Pyrexia, Troponin increased
SMQs:, Acute pancreatitis (broad), Neuroleptic malignant syndrome (broad), Systemic lupus erythematosus (broad), Myocardial infarction (narrow), Anticholinergic syndrome (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Cardiomyopathy (broad), Chronic kidney disease (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Immune-mediated/autoimmune disorders (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 3 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type:

Write-up: 16 year old male who presents with sudden onset chest pain. Patient states that he woke up with sudden chest pain at about 3:30 a.m. this morning and later fell asleep again as the pain was better. Around 9:30 AM he had worsening chest pain with some radiation to the left arm and his mother took him to the ED for further evaluation. He received his 2nd dose of the Pfizer COVID-19 vaccine on 7/6/2021 (first dose June 9th). In the subsequent days after receiving the vaccine he had a low-grade (less than 100? F) fever at home accompanied by some headache. Beginning on Wednesday July 7th he began to take 400 mg ibuprofen every 6 to 7 hours with his last dose being at 9 p.m. last night. Upon arrival to the ED did feel nauseous and continued to have chest pain however symptoms were relieved after receiving a dose of ibuprofen. He has never had symptoms like this before. He describes the chest pain as a constant dull pain that hurts slightly more with breathing. In the ED lab work revealed an elevated troponin of 3.8 with ST elevation on EKG. Admitted to the hospital Primary Discharge Diagnosis Acute Myocarditis /Pericarditis


VAERS ID: 1532060 (history)  
Form: Version 2.0  
Age: 16.0  
Sex: Male  
Location: Pennsylvania  
Vaccinated:2021-07-22
Onset:2021-07-31
   Days after vaccination:9
Submitted: 0000-00-00
Entered: 2021-08-06
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EW0158 / 2 RA / IM

Administered by: Private       Purchased by: ?
Symptoms: Atrioventricular block second degree, Bilirubin conjugated, Blood albumin, Blood bilirubin, Blood catecholamines, Blood creatine phosphokinase, Blood culture, Blood gases, Brain natriuretic peptide, C-reactive protein, Cardiac pacemaker insertion, Chest X-ray, Coagulation test, Differential white blood cell count, Dizziness, Electrocardiogram, Full blood count, Glycosylated haemoglobin, Inflammatory marker test, Intensive care, Laboratory test normal, Lipids, Magnetic resonance imaging heart, Metabolic function test, Red blood cell sedimentation rate, Seizure like phenomena, Syncope, Thyroid function test, Toxicologic test, Troponin, Viral test
SMQs:, Torsade de pointes/QT prolongation (broad), Anticholinergic syndrome (broad), Arrhythmia related investigations, signs and symptoms (broad), Conduction defects (narrow), Convulsions (narrow), Cardiomyopathy (broad), Vestibular disorders (broad), Hypotonic-hyporesponsive episode (broad), Hypoglycaemia (broad), Hypokalaemia (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 6 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: Melatonin as needed
Current Illness: None
Preexisting Conditions: None at time of vaccine
Allergies: Azithromycin: hives
Diagnostic Lab Data: BMP, CMP, CBC with diff, coagulation studies, blood gases, T bili, D bili, albumin, lipids, CPK, troponins, BNP, HbA1c, thyroid function tests, metanephrines, CRP, ESR, viral panel, toxicology screen, blood culture, CXR, cardiac MRI, EKG. These tests were ordered, some multiple times, throughout the patient''s 6 day hospital stay. In summary, inflammatory markers and infectious workup was negative.
CDC Split Type:

Write-up: One week after the patient received the second dose of the COVID-19 Pfizer vaccine, he started experiencing episodes of seizure-like activity, dizziness, and syncope. He experienced these symptoms on day 9 after receiving the vaccine, and continued experiencing episodes on day 10 when he presented to the emergency department. He was diagnosed with high-grade second degree heart block, requiring the implantation of the pacemaker and a 6 day hospitalization with time in the pediatric intensive care unit. The patient is improving clinically is currently still in a deconditioned state however is recovering from the new diagnosis and recent procedure.


VAERS ID: 1532266 (history)  
Form: Version 2.0  
Age: 14.0  
Sex: Male  
Location: Utah  
Vaccinated:2021-07-30
Onset:2021-07-31
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2021-08-06
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH ER8736 / 2 - / IM

Administered by: Pharmacy       Purchased by: ?
Symptoms: Adenovirus test, Alanine aminotransferase normal, Aspartate aminotransferase increased, Asthenia, Blood alkaline phosphatase increased, Blood creatinine normal, Blood culture negative, Blood electrolytes normal, Brain natriuretic peptide increased, C-reactive protein increased, Chest X-ray normal, Chest pain, Cough, Cytomegalovirus test negative, Cytomegalovirus test positive, Dyspnoea, Electrocardiogram ST segment elevation, Enterovirus test negative, Epstein-Barr virus antibody negative, Fatigue, Full blood count abnormal, HIV antibody negative, Haemodynamic test normal, Haemoglobin normal, Headache, Hepatitis viral test negative, Herpes simplex test negative, Human herpes virus 6 serology negative, Liver function test normal, Neutrophil count, Pain in extremity, Parvovirus B19 test negative, Platelet count normal, Red blood cell sedimentation rate normal, Respiratory viral panel, SARS-CoV-2 antibody test positive, Sleep disorder, Troponin increased, Varicella virus test negative, Viral test negative, White blood cell count increased
SMQs:, Cardiac failure (broad), Liver related investigations, signs and symptoms (narrow), Anaphylactic reaction (broad), Haematopoietic leukopenia (broad), Neuroleptic malignant syndrome (broad), Myocardial infarction (narrow), Acute central respiratory depression (broad), Biliary system related investigations, signs and symptoms (broad), Pulmonary hypertension (broad), Guillain-Barre syndrome (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (broad), Cardiomyopathy (broad), Tendinopathies and ligament disorders (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Infective pneumonia (broad), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 5 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: PRN ibuprofen
Current Illness: None
Preexisting Conditions: None
Allergies: Azithromycin - rash Penicillin - rash
Diagnostic Lab Data: 8/2: troponin 9.24 and BNP 26. Viral respiratory panel was obtained and negative. CRP slightly elevated at 2.5. and a normal ESR at 2 CBC had a WBC 7.2 without evidence of a shift, Hgb 16.4, platelets 277, ANC 4. Electrolytes were appropriate and creatinine was 0.81. LFTs were notable for a normal alk phos 197, slightly elevated AST at 61, and normal ALT 28. 8/3 troponin: 6.64, 6.56, 6.74, 8.31 8/4 troponin: 7.61, 4.45, 3.85, 4.42, 4.49, 3.60, 2.95 8/6 troponins 1.96 and 1.74 Infectious work-up: Adenovirus (VRP and NP swab negative) CMV IgG +, IgM - COVID-19 IgG by CIA Spike protein: positive EBV antibody panel: negative Enterovirus (serum PCR): negative Hepatitis panel: negative HHV6: negative HSV: negative HIV 1/2 Ab/Ag: non-reactive Parvovirus IgG+ and IgM- VRP: negative VZV IgG+, IgM- Infectious work-up still pending: Blood cultures (no growth to date) Enterovirus culture (in process) COVID IgG qualitative CIA (Nucleocapsid) For results of pending tests or additional clinical information, please contact the hospital.
CDC Split Type:

Write-up: Patient is a previously healthy child without known chronic medical conditions and is full-immunized. He received his first Pfizer COVID vaccine on 7/9 which he tolerated well with the exception of a sore arm. He received his second Pfizer COVID vaccine on Friday, 7/30. He endorses a headache and arm soreness that day but otherwise felt well. Saturday (7/31) he was in his usual state of health until that night when he woke up with central chest pain that was worse with laying down. The pain was not worse with deep breathing, coughing, or other activities. Sunday morning the pain improved slightly but was still there. Sunday night to Monday morning the pain significantly worsened and parents took him to a clinic for evaluation. Dad reports that while they were checking in, patient was very short of breath and significantly fatigued. Denies fevers, chills, myalgias, abdominal pain, n/v, diarrhea, sore throat, rashes. Chest x-ray at an outside clinic was normal and EKG showed diffuse ST elevation, concerning for pericarditis, , possibly postvaccination. Dad reports that the clinic arranged for patient to be directly admitted to hospital for further evaluation. Following the clinic visit and prior to arriving at hospital, his pain did improve slightly as did his SOB. Upon arrival to hospital, he was hemodynamically stable. Labs were notable for a troponin 9.24 and BNP 26. Viral respiratory panel was obtained and negative. CRP slightly elevated at 2.5. and a normal ESR at 2 CBC had a WBC 7l.2 without evidence of a shift, Hgb 16.4, platelets 277, ANC 4. Electrolytes were appropriate and creatinine was 0.81. LFTs were notable for a normal alk phos 197, slightly elevated AST at 61, and normal ALT 28. Since admission patient reports that his chest pain has resolved and that his energy has returned. His troponin continues to be elevated but is downtrending (6.56 this morning). He has been afebrile and his blood culture is currently no growth. The week prior to his admission, patient denies any diarrhea, nasal congestion, cold symptoms, or recently illnesses. His Dad does endorse having a cold over the past week with nasal congestion and a mild sore throat. Please see below for full exposure history but largely, exposure history is benign with no recent travel, no significant bug bites or concern for rickettsial diseases, and low risk for Salmonella or other bacterial infections.


VAERS ID: 1536512 (history)  
Form: Version 2.0  
Age: 13.0  
Sex: Male  
Location: Massachusetts  
Vaccinated:2021-07-07
Onset:2021-07-17
   Days after vaccination:10
Submitted: 0000-00-00
Entered: 2021-08-09
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EW0181 / 2 LA / IM

Administered by: Private       Purchased by: ?
Symptoms: Abdominal discomfort, Abdominal pain, Anxiety, C-reactive protein increased, Cardiac imaging procedure abnormal, Chest X-ray normal, Chest discomfort, Chest pain, Diarrhoea, Dyspnoea, Echocardiogram normal, Ejection fraction decreased, Electrocardiogram ST segment elevation, Epstein-Barr virus antibody positive, Fibrin D dimer increased, Haemoglobin decreased, Headache, Hypertension, Immunoglobulin therapy, Inflammatory marker test, Irritability, Limb discomfort, Magnetic resonance imaging heart, Mycoplasma test positive, Myocarditis, Painful respiration, Pyrexia, Red blood cell sedimentation rate increased, SARS-CoV-2 antibody test negative, Troponin T increased, Viral myocarditis, White blood cell count normal
SMQs:, Cardiac failure (narrow), Anaphylactic reaction (broad), Acute pancreatitis (broad), Haematopoietic erythropenia (broad), Haemorrhage laboratory terms (broad), Neuroleptic malignant syndrome (broad), Myocardial infarction (narrow), Anticholinergic syndrome (broad), Retroperitoneal fibrosis (broad), Pseudomembranous colitis (broad), Gastrointestinal perforation, ulcer, haemorrhage, obstruction non-specific findings/procedures (broad), Acute central respiratory depression (broad), Pulmonary hypertension (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Hostility/aggression (broad), Hypertension (narrow), Cardiomyopathy (narrow), Noninfectious diarrhoea (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Hypoglycaemia (broad), Infective pneumonia (broad), Opportunistic infections (broad), Immune-mediated/autoimmune disorders (broad), COVID-19 (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 5 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: Miralax, tretinoin 0.025% cream
Current Illness: None
Preexisting Conditions: Hypertension, mild intermittent asthma, constipation
Allergies: Seasonal
Diagnostic Lab Data: 7/20/2021: Cardiac MRI: Normal biventricular size and systolic function. No regional wall motion abnormalities. Left ventricular late gadolinium enhancement is present: A mid-myocardial to subepicardial distribution of late gadolinium enhancement is noted at the inferior basal segment.. Otherwise, no significant myocardial hyperintensity on T2-weighted (edema) imaging.Also, myocardial native T1, T2, and extracellular volume fraction are normal. Myocardial diffuse fibrosis, ruled out. Extracellular volume fraction is normal. Myocardial edema, ruled out.No significant myocardial hyperintensity on T2-weighted (edema) imaging. Left ventricular global systolic function, normal Left ventricular late gadolinium enhancement No significant valvular dysfunction. Normal coronary artery origins. No coronary artery aneurysms. Trivial pericardial effusion. 7/20/2021: Echocardiogram: ? Normal valvular function. ? Normal left ventricular size and systolic function. ? Normal indices of diastolic function and longitudinal/circumferential strain. ? Normal proximal coronary arteries. ? Qualitatively normal right ventricular systolic function. ? No pericardial effusion. ? At least one right and one left pulmonary vein connect normally to the left atrium. EBV PCR - Final - July 21, 2021 15:27 EDT - EBV DNA detected by PCR. 2,400 copies of the EBV genome detected per mL which corresponds to 3.4 log10 copies of the EBV genome per mL. A reference range for this test has not been established. Results should be interpreted in the context of other clinical and laboratory information. This test should not be used to diagnose latent or previous EBV infection. People with latent or previous EBV infection may not have detectable EBV DNA by this test. The variability of this test should be considered when interpreting results. Changes of approximately three fold in the quantity of EBV DNA detected may be due to variation in the test rather than actual changes in the level of EBV DNA in the sample. Note: This test was developed and its performance characteristics determined by the Infectious Diseases Diagnostic Division of Hospital. It has not been cleared or approved by the Food and Drug Administration. The FDA has determined that such clearance or approval is not necessary. EBV Ab to NA, IgG $g 600 EBV Capsid Antigen, IgG 92.6 Mycoplasma pneumoniae, IgG 118 CRP peak 9.35 mg/dL Troponin T peak 0.23 ng/mL ESR peak 130 mm/hr D-Dimer peak 1.05 mcg/mL
CDC Split Type:

Write-up: Admission Date/Time: 07/19/2021 20:06:00 Discharge Date/Time: 07/23/2021 11:31:21 Chief Complaint chest pain Patient Narrative ILLNESS SEVERITY: The patient is stable, returning to baseline. PATIENT SUMMARY: Reason for Hospitalization: Chest discomfort, myocarditis. Admission HPI: a 13 year old boy with a history of hypertension and mild intermittent asthma who is presenting with several hours of shortness of breath and chest discomfort with deep breaths. 2 days ago prior to presentation, he developed a low grade fever that lasted for 1 day. He did not measure a temperature but took some Motrin. At the same time he was experiencing abdominal pain and diarrhea, the latter of which has persisted. He does not think the diarrhea has been bloody but is unable to describe the color or consistency. The day of presentation, he began experiencing mid-sternal chest discomfort that sometimes worsened with deep breaths, though not every deep breath. It was associated with a mild headache. He denies palpitations, light headedness, orthopnea, or syncope. No other symptoms of illness including cough, congestion, runny nose, itchy eyes, rash, wheezing, or emesis. No known sick contacts. Given the nature of his chest pain, he presented to the ED for further evaluation. Of note, he received his 2nd Pfizer Covid vaccine on July 7. He experienced some mild arm discomfort afterwards but no fevers/myalgias/chest pain in the following days. In the ED, he was well appearing with normal vital signs. He denied any active chest pain or shortness of breath, though continued to endorse mild abdominal discomfort. An EKG was performed which was notable for diffusely elevated ST segments, particularly in leads II and III. Labs are significant for elevated troponin to 0.13, d-dimer to 1.05, ESR of 76, CRP of 9.35, WBC 9, Hgb 11.9, and negative covid antibodies. CXR was benign. Decision was made to admit to Cardiology for close monitoring and further workup. PMH: significant for elevated blood pressures in the past, seen in Nephrology clinic in 2019 with unremarkable workup including renal ultrasound, blood and urine studies. Believed to be in large part attributed to anxiety, though does have a family history of ESRD. Surg: T&A at 4-5 years of age Allergies: NKA Meds: only PRN albuterol (last used 1 year ago) Fam history: + for ESRD, negative for cardiac or autoimmune diseases Social: everyone at home healthy, nobody has had COVID. Going into 8th grade, wants to learn about space Hospital Course: He was admitted to the cardiology floor for continued monitoring of his troponin levels and EKG. His chest pain resolved shortly after admission and he remained asymptomatic through admission. The morning after his admission, his troponin was stable at 0.12 and echocardiogram showed no abnormalities with normal function. Troponins were trended and remained stable. Inflammatory markers were trended and improved. Cardiac MRI performed prior to treatment showed a small area over the posterior LV free wall of late gadolinium enhancement. EKG showed stable ST elevation in inferior and lateral leads. Presentation was most consistent with viral myocarditis. Given increasing troponin, he was treated with IVIG (2g/kgx1) and steroids (5 day total). His inflammatory markers down trended and resolution of symptoms throughout admission (ESR falsely elevated after IVIG), and had improvement in his troponin after treatment with IVIG and steroids. EKG were stable during admission. By time of discharge, patient was well-appearing, vitals stable, demonstrating good PO intake. Chest pain was fully resolved. Follow up with cardiology in place. Discharge instructions and return precautions reviewed with patient and parent, who expressed good understanding and agreement with plan. Given history of elevated blood pressures, also demonstrated during admission here, and evaluation by nephrology in past, he was set up with nephrology follow up as an outpatient. Reasons for new, changed, and discontinued medications: none Reasons for new, changed, and discontinued equipment: NA Relevant Diagnostic Images/Studies: CXR on 7/19 IMPRESSION: Normal chest examination. Diagnosis List 1. Shortness of breath, 07/20/2021 2. Myocarditis, 07/20/2021 Patient Instructions He was admitted for management of myocarditis thought to be due to a virus. He had multiple EKGs, echocardiograms, and a cardiac MRI which showed mild changes but overall good heart function. His chest pain and heart studies improved throughout his stay and he was safe for discharge home. He should take the following medications when going home: - Prednisolone 30 mg twice per day, with last dose on 7/26 in the morning - Famotidine 20mg twice per day, while taking steroids. It is important for him to minimize activity that raises his heart rate for the next 3 months. This will be discussed in more detail at his cardiology appointment. Until then, no strenuous exercise. 8/5/2021 clinic follow up: Cardiology Diagnostics EKG: WNL Echo: Normal function LV short-axis % area change 50.2 % -0.9 54.4 44.9 63.9 LV ejection fraction (area-length) 57.1 % -1.4 63.0 55.0 72.0 Labs noted in right hand column. CRP still elevated (higher than at discharge). Assessment/Plan Since his discharge, he has had headaches every almost every day. He thinks this is improving slowly but he has had about 2-3 headaches a day. He has had Tylenol and Motrin and this helps. He describes the pain as 4-5 /10 on the pain scale. He has not had any chest pain, no dizziness, no palpitations, no syncope. His mother says he is crankier than usual and she is concerned about his headache. The patient is 75% back to normal in terms of energy; 100% back to baseline in terms of appetite; 100% back to normal in terms of sleep; 100% back to baseline in terms of cognition and 50 % back to normal in terms of personality/mood. In summary, he is a 13 yo boy with a recent history of myocarditis. The etiology (viral vs late-post vaccine) is unclear. His LV function has always been WNL but he had an elevated troponin and evidence of myocarditis by Cardiac MRI with LGE. His BP had been noted to be somewhat high. This was checked today by auscultation and was 114/64 RA adult cuff.


VAERS ID: 1540782 (history)  
Form: Version 2.0  
Age: 17.0  
Sex: Male  
Location: Ohio  
Vaccinated:2021-07-16
Onset:2021-08-09
   Days after vaccination:24
Submitted: 0000-00-00
Entered: 2021-08-10
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EW0164 / 1 LA / IM

Administered by: Private       Purchased by: ?
Symptoms: Myocarditis
SMQs:, Cardiomyopathy (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Immune-mediated/autoimmune disorders (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type:

Write-up: Myocarditis


VAERS ID: 1545275 (history)  
Form: Version 2.0  
Age: 14.0  
Sex: Male  
Location: California  
Vaccinated:2021-07-28
Onset:2021-07-31
   Days after vaccination:3
Submitted: 0000-00-00
Entered: 2021-08-11
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EW0191 / 1 LA / IM

Administered by: Private       Purchased by: ?
Symptoms: Chest pain, Echocardiogram normal, Electrocardiogram abnormal, Immunoglobulin therapy, Loss of personal independence in daily activities, Myocarditis, Troponin increased
SMQs:, Myocardial infarction (narrow), Arrhythmia related investigations, signs and symptoms (broad), Dementia (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (broad), Cardiomyopathy (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Immune-mediated/autoimmune disorders (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 4 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: None
Current Illness: None
Preexisting Conditions: Speech language delay
Allergies: nka
Diagnostic Lab Data: Results for patient as of 8/11/2021 11:15 7/30/2021 23:09 TROPONIN I: 7.81 (H) 7/31/2021 05:10 TROPONIN I: 15.81 (H) 7/31/2021 11:10 TROPONIN I: 9.16 (H) 7/31/2021 20:00 TROPONIN I: 6.28 (H) 8/1/2021 06:25 TROPONIN I: 8.93 (H) 8/2/2021 05:15 TROPONIN I: 7.44 (H) 8/3/2021 06:00 TROPONIN I: 1.36 (H) 8/3/2021 17:21 TROPONIN I: 0.76 (H) 8/5/2021 16:07 TROPONIN I: 0.23 (H)
CDC Split Type:

Write-up: 14y/o M received his 2nd dose of Pfizer COVID vaccine on 7/28 and started to complain of chest pain on 7/30. Pain worsened to 8/10 and he was seen in the ED that evening with an ECG suggestive of acute myopericarditis and positive troponin of 7.81. He was admitted for likely post-covid vaccine myopericarditis. His was initially treated with ibuprofen overnight with no complains of chest pain the following morning 7/31, and continued to be asymptomatic throughout the rest of his hospital course. Troponin on 7/31 AM was up to 15.81. An echo was completed and showed normal cardiac size and function without pericardial effusion. He was acutely treated with IVIG continuously for for 9 hours, and Ibuprofen q8 hour for a total of 4 days. Troponin was trended daily with gradual improvement to 1.36 on morning of discharge. A repeat echo was performed that was normal. Given that a repeat troponin level on 8/3 PM was 0.76, he was deemed to be stable for discharge by Pediatric Cardiology. He will need to be restricted from strenuous activities with no competitive sports or physical education for 3 months per cardiology. Pediatric Cardiology will continue to follow him as an outpatient, monitoring him 2-day post-discharge troponin level and will perform an exercise stress test in 3 months. Discharged on 7 more days of Motrin TID w meals


VAERS ID: 1545388 (history)  
Form: Version 2.0  
Age: 15.0  
Sex: Female  
Location: Arizona  
Vaccinated:2021-07-02
Onset:2021-08-02
   Days after vaccination:31
Submitted: 0000-00-00
Entered: 2021-08-11
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 1 - / -

Administered by: Private       Purchased by: ?
Symptoms: Acute kidney injury, Anion gap, Antinuclear antibody negative, Blood creatine phosphokinase normal, Blood creatinine increased, Blood urea increased, Blood urine, Complement factor C3, Complement factor C4, Diarrhoea, Echocardiogram normal, Immunology test normal, Inflammatory marker increased, Metabolic function test, Protein urine present, Red blood cells urine, Ultrasound Doppler normal, Vomiting, pH urine normal
SMQs:, Rhabdomyolysis/myopathy (broad), Acute renal failure (narrow), Acute pancreatitis (broad), Haemorrhage terms (excl laboratory terms) (narrow), Haemorrhage laboratory terms (narrow), Systemic lupus erythematosus (broad), Retroperitoneal fibrosis (broad), Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (broad), Torsade de pointes, shock-associated conditions (broad), Hypovolaemic shock conditions (broad), Toxic-septic shock conditions (broad), Anaphylactic/anaphylactoid shock conditions (broad), Hypoglycaemic and neurogenic shock conditions (broad), Pseudomembranous colitis (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Chronic kidney disease (broad), Noninfectious diarrhoea (narrow), Tumour lysis syndrome (broad), Proteinuria (narrow), Tubulointerstitial diseases (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Dehydration (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 3 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: None
Current Illness: None
Preexisting Conditions: None
Allergies: None
Diagnostic Lab Data: Labs significant for a BUN of 24 and creatinine of 2.7, anion gap of 15, an otherwise normal CMP, and urine dipstick with 1+ protein and 2+ blood with 1 RBC, and urine pH of 5.0 CK normal. Doppler US of kidneys normal and ECHO was normal. We considered possible MIS-C as she had COVID infection in December, however this possibility was discussed with ID and felt to be very unlikely, she did not meet any diagnostic criteria given her lack of documented fever and she had spontaneous improvement in symptoms and labs without treatment. C3 and C4 were both normal, and ANA was negative. During hospitalization, creatinine downtrending (1.92 at discharge).
CDC Split Type:

Write-up: Patient admitted with vomiting, diarrhea, acute kidney injury, elevated inflammatory markers, but did not have fever so not diagnosed with MISC. Patient also had vomiting and diarrhea so this may have been from another acute illness and had nothing to do with the vaccine.


VAERS ID: 1549043 (history)  
Form: Version 2.0  
Age: 14.0  
Sex: Female  
Location: Unknown  
Vaccinated:2021-07-21
Onset:2021-08-08
   Days after vaccination:18
Submitted: 0000-00-00
Entered: 2021-08-12
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EW0164 / UNK - / -

Administered by: Unknown       Purchased by: ?
Symptoms: Suicide attempt
SMQs:, Suicide/self-injury (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type:

Write-up: Suicide attempt.


Result pages: prev   1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18   next

New Search

Link To This Search Result:

https://www.medalerts.org/vaersdb/findfield.php?EVENTS=ON&PAGENO=9&VAX=COVID19&VAXMAN=PFIZER/BIONTECH&HOSPITAL=Yes&DIED=No&WhichAge=range&LOWAGE=(0)&HIGHAGE=(19)&VAX_YEAR_LOW=2021&VAX_MONTH_LOW=07&VAX_YEAR_HIGH=2021&VAX_MONTH_HIGH=07


Copyright © 2022 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166